| [1] |
Grinyó JM. Why is organ transplantation clinically important?[J]. Cold Spring Harb Perspect Med, 2013, 3(6): a14985. doi: 10.1101/cshperspect.a014985
|
| [2] |
Mccarthy DP, Bryant J, Galvin JP, et al. Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells[J]. Am J Transplant, 2015, 15(6): 1475, 1483. doi: 10.1111/ajt.13237
|
| [3] |
Chen JC, Kuo ML, Ou LS, et al. Characterization of tolerance induction through prenatal marrow transplantation: the requirement for a threshold level of chimerism to establish rather than maintain postnatal skin tolerance[J]. Cell Transplant, 2010, 19(12): 1609-1622. doi: 10.3727/096368910X516583
|
| [4] |
Yamada Y, Ochiai T, Boskovic S, et al. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates[J]. Am J Transplant, 2014, 14(12): 2704-2712. doi: 10.1111/ajt.12936
|
| [5] |
Song J, Huang J, Chen X, et al. Donor-derived exosomes induce specific regulatory T cells to suppress immune inflammation in the allograft heart[J]. Sci Rep, 2016, 7: 20077. doi: 10.1038/srep20077
|
| [6] |
Yu Y, Zitzner JR, Houlihan J, et al. Common gamma chain cytokines promote rapid in vitro expansion of specific human CD8+ suppressor T cells[J]. PLoS One, 2011, 6(12): e28948. doi: 10.1371/journal.pone.0028948
|
| [7] |
Kim JI, Rothstein DM, Markmann JF. Role of B cells in tolerance induction[J]. Curr Opin Organ Transplant, 2015, 20(4):369-375. doi: 10.1097/MOT.0000000000000204
|
| [8] |
Orandi BJ, Zachary AA, Dagher NN, et al. Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation[J]. Transplantation,2014, 98(8): 857-863. doi: 10.1097/TP.0000000000000298
|
| [9] |
Zhao Y, Gillen JR, Meher AK, et al. Rapamycin prevents bronchiolitis obliterans through increasing infiltration of regulatory B cells in a murine tracheal transplantation model[J]. J Thorac Cardiovasc Surg, 2016, 151(2): 487-496. doi: 10.1016/j.jtcvs.2015.08.116
|
| [10] |
Newell KA, Asare A, Kirk AD, et al. Identification of a B cell signature associated with renal transplant tolerance in humans[J]. J Clin Invest, 2010, 120(6): 1836-1847. doi: 10.1172/JCI39933
|
| [11] |
Ong LP, Sachdeva A, Ramesh BC, et al. Lung transplant with cardiopulmonary bypass: impact of blood transfusion on rejection, function, and late mortality[J]. Ann Thorac Surg, 2016, 101(2): 512-519. doi: 10.1016/j.athoracsur.2015.07.048
|
| [12] |
Gao XW, Fu Y, Li WJ, et al. Mechanism of immune tolerance induced by donor derived immature dendritic cells in rat high-risk corneal transplantation[J]. Int J Ophthalmol, 2013, 6(3): 269-275. http://cn.bing.com/academic/profile?id=149443528&encoded=0&v=paper_preview&mkt=zh-cn
|
| [13] |
Miller SD, Wetzig RP, Claman HN. The induction of cell- mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells[J]. J Exp Med, 1979, 149(3): 758-773. doi: 10.1084/jem.149.3.758
|
| [14] |
Law S, Benham H, Reid HH, et al. Identification of self-antigen-specific T cells reflecting loss of tolerance in autoimmune disease underpins preventative immunotherapeutic strategies in rheumatoid arthritis[J]. Rheum Dis Clin North Am, 2014, 40(4): 735-752. doi: 10.1016/j.rdc.2014.07.015
|
| [15] |
Taba K, Shusen W, Jane B, et al. Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance[J]. J Immunol, 2012, 189(2): 804-812. doi: 10.4049/jimmunol.1103705
|
| [16] |
Wang S, Zhang X, Zhang L, et al. Preemptive tolerogenic delivery of donor antigens for permanent allogeneic islet graft protection.[J]. Cell Transplant, 2014, 24(6):1155-1165. http://cn.bing.com/academic/profile?id=97502527&encoded=0&v=paper_preview&mkt=zh-cn
|
| [17] |
Chen G, Kheradmand T, Bryant J, et al. Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions[J]. Am J Transplant, 2012, 12(11): 2920-2929. doi: 10.1111/j.1600-6143.2012.04203.x
|
| [18] |
Boursier G, Siri A, de Boysson H. Use of regulatory T cells in cellular therapies in autoimmune diseases [J]. Med Sci, 2012, 28(8/9): 757-763. http://cn.bing.com/academic/profile?id=132257601&encoded=0&v=paper_preview&mkt=zh-cn
|
| [19] |
Lei J, Kim JI, Shi S, et al. Pilot study evaluating regulatory T cell-promoting immunosuppression and nonimmunogenic donor antigen delivery in a nonhuman pimate islet allotransplantation model[J]. Am J Transplant, 2015, 15(10): 2739-2749. doi: 10.1111/ajt.13329
|
| [20] |
Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity[J]. Immunol Rev, 2010, 236(1): 219-242. doi: 10.1111/j.1600-065X.2010.00923.x
|
| [21] |
Yang J, Riella L V, Chock S, et al. The novel costimulatory programmed death ligand 1/B7.1 pathway is functional in inhibiting alloimmune responses in vivo[J]. J Immunol, 2011, 187(3): 1113-1119. doi: 10.4049/jimmunol.1100056
|
| [22] |
Wang H, Wu XY, Oldenborg PA, et al. CD47 is required for suppression of allograft rejection by donor-specific transfusion[J]. J Immunol, 2010, 184(7): 3401-3407. doi: 10.4049/jimmunol.0901550
|
| [23] |
Rodríguez-García M,Porichis F, de Jong OG, et al. Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10[J]. J Leukoc Biol, 2010, 89(4): 507-515. http://cn.bing.com/academic/profile?id=2125068253&encoded=0&v=paper_preview&mkt=zh-cn
|
| [24] |
Chen G, Li J, Chen L, et al. ECDI-fixed allogeneic splenocytes combined with α1-antitrypsin prolong survival of rat renal allografts[J]. Int Immunopharmacol, 2015, 26(1): 43-49. doi: 10.1016/j.intimp.2015.02.035
|
| [25] |
Flrcken A, Takvorian A, Singh A, et al. Myeloid-derived suppressor cells in human peripheral blood: optimized quantification in healthy donors and patients with metastatic renal cell carcinoma[J]. Immunol Lett,2015,168(2):260-267. doi: 10.1016/j.imlet.2015.10.001
|
| [26] |
Bryant J, Lerret NM, Wang JJ, et al. Preemptive donor apoptotic cell infusions induce IFN -γ- producing myeloid-derived suppressor cells for cardiac allograft protection[J]. J Immunol, 2014, 192(12): 6092-6101. doi: 10.4049/jimmunol.1302771
|
| [27] |
Martin AJ, Mccarthy DC, Goings G, et al. Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation[J]. J Immunol, 2010, 185(6): 3326-3336. doi: 10.4049/jimmunol.1000802
|
点击查看大图
下载:
